Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.07M Sell
17,242
-97
-0.6% -$33.2K 0.48% 24
2026
Q1
$6.1M Buy
17,339
+1,271
+8% +$453K 0.47% 24
2025
Q4
$5.26M Buy
+16,068
New +$5.1M 0.36% 50

Other funds holding AMGN

Sherman Porfolios's AMGN Position: Q2 2026 in Review

Sherman Porfolios reduced its Amgen (AMGN) stake by 0.56% in Q2 2026, selling an estimated $33.2K and leaving 17,242 shares worth $6.07M. The position accounts for 0.48% of the portfolio, ranked #24.

Sherman Porfolios first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $6.1M in Q1 2026. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Sherman Porfolios held 17,242 shares of Amgen worth $6.07M as of Q2 2026.
  • Sherman Porfolios sold 97 Amgen shares in Q2 2026, an estimated $33.2K.
  • Amgen made up 0.48% of Sherman Porfolios's portfolio in Q2 2026, its #24 holding.
  • Sherman Porfolios first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
  • Sherman Porfolios's Amgen position peaked at $6.1M in Q1 2026.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Sherman Porfolios's 13F filing for Q2 2026, filed 12 Aug 2026.